|
DK3616720T3
(da)
|
|
Farmaceutisk sammensætning til cancerbehandling
|
|
HK1257373A1
(zh)
|
|
雙功能蛋白質和包含其的藥物組合物
|
|
IL287500A
(en)
|
|
Therapeutic preparations from pooled apoptotic blood cells and their use
|
|
IL258246B
(en)
|
|
Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
|
|
IL258854A
(en)
|
|
Preparations containing cannabidiol and secondary medicinal agents for cancer treatment
|
|
IL253243A0
(en)
|
|
Combined preparations for the treatment of cancer or infection
|
|
GB201411465D0
(en)
|
|
Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
|
|
BR112016018062A2
(pt)
|
|
compostos terapêuticos, composição farmacêutica e usos
|
|
DK3532067T3
(da)
|
|
Liposomal formulering til anvendelse til behandling af cancer
|
|
BR112016027043A2
(pt)
|
|
Combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
|
|
SG11201605868XA
(en)
|
|
Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
|
|
TR201910866T4
(tr)
|
|
Kanser tedavisi için birleşik preparasyonlar.
|
|
HK1256674A1
(zh)
|
|
氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
|
|
WO2014121137A3
(en)
|
|
Compositions and methods for the treatment of neurodegenerative and other diseases
|
|
EP3150212A4
(en)
|
|
Pharmaceutical solution having anti-tumor effect-enhancing and toxicity-reducing effect, and pharmaceutical composition comprising same
|
|
IL266486A
(en)
|
|
Pharmaceutical preparations and methods for cancer treatment
|
|
ZA201900121B
(en)
|
|
Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
|
|
IL274008A
(en)
|
|
Anti-MSLN antibody and a pharmaceutical preparation containing it for the treatment of cancer
|
|
EP3398608A4
(en)
|
|
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER OR CANCER METASTASES WITH PSTL1-PRTEIN AS AN ACTIVE SUBSTANCE
|
|
EP3290051A4
(en)
|
|
Pharmaceutical composition for treating and/or preventing cancer
|
|
PL3262047T3
(pl)
|
|
Pochodne imidazopirymidyny i imidazotriazyny i kompozycje farmaceutyczne je zawierające
|
|
EP3563856A4
(en)
|
|
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND USE THEREOF
|
|
IL249860A0
(en)
|
|
Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
|
|
EP3372233A4
(en)
|
|
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
|
|
GB201519644D0
(en)
|
|
Therapy and pharmaceutical composition
|